Assistant Clinical Professor of Medicine, Jefferson Medical College
Infectious Disease
Dr. Joseph A. Desimone Jr., MD
|
|
Give Review
Joseph A. Desimone Jr., MD works in the field of Infectious Disease. He attended Drexel University College of Medicine. He has 1 awards "CMS Meaningful Use Stage 1 Certification". Doctor Joseph A. Desimone Jr., MD is also a published doctor. He has 39 paper published. The most recent paper is: Increased binding of Sp1 to the gamma-globin gene promoter upon site-specific cytosine methylation.
Publications
- The LSD1 inhibitor RN-1 recapitulates the fetal pattern of hemoglobin synthesis in baboons (P. anubis).
- Hepatitis B reverse seroconversion in a patient with well controlled HIV infection: a case report and a review of the literature.
- Dolutegravir: A New Integrase Strand Transfer Inhibitor for the Treatment of HIV - An Alternative Viewpoint.
- Dolutegravir: A New Integrase Strand Transfer Inhibitor for the Treatment of HIV.
- Haemoglobinuria is associated with chronic kidney disease and its progression in patients with sickle cell anaemia.
- Rothia mucilaginosa Prosthetic Device Infections: A Case of Prosthetic Valve Endocarditis.
- A Fatal Case of Weeksella virosa Sepsis and a Review of the Literature.
- Bloodstream infections in hospitalized adults with sickle cell disease: a retrospective analysis.
- Attenuation of HIV-1 infection by other microbial agents.
- Antiretroviral therapy in the developing world.
- Successful desensitization to enfuvirtide after a hypersensitivity reaction in an HIV-1-infected man.
- Treatment of Mycobacterium avium complex immune reconstitution disease in HIV-1-infected individuals.
- Infection of transjugular intrahepatic portosystemic shunt devices.
- Sensorineural hearing loss associated with intrathecal vancomycin.
- New methods for the detection of HIV.
- Tobacco use in HIV-infected women.
- Central nervous system infections in individuals with HIV-1 infection.
- Anti-HIV-1 microbicides -- ''chemical condoms'' designed to limit the scourge of the HIV-1 pandemic.
- Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy.
- Human immunodeficiency virus type 1-infected persons with residual disease and virus reservoirs on suppressive highly active antiretroviral therapy can be stratified i...
- Intensification and stimulation therapy for human immunodeficiency virus type 1 reservoirs in infected persons receiving virally suppressive highly active antiretrovir...
- Sustained bacteremia associated with transjugular intrahepatic portosystemic shunt (TIPS).
- Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy.
- Candidemia complicated by endophthalmitis: a prospective analysis.
- Lead-associated endocarditis: the important role of methicillin-resistant Staphylococcus aureus.
- Prevalence of obstructive lung disease in HIV population: a cross sectional study.
- Pain, coping and health care utilization in younger and older adults with sickle cell disease.
- Clinical effectiveness of decitabine in severe sickle cell disease.
- Oral decitabine reactivates expression of the methylated gamma-globin gene in Papio anubis.
- Histone deacetylase inhibitors increase p21(WAF1) and induce apoptosis of human myeloma cell lines independent of decreased IL-6 receptor expression.
- Fetal hemoglobin reactivation in baboon and man: a short perspective.
- Increased binding of Sp1 to the gamma-globin gene promoter upon site-specific cytosine methylation.
- Effects of 5-aza-2'-deoxycytidine on fetal hemoglobin levels, red cell adhesion, and hematopoietic differentiation in patients with sickle cell disease.
- Clinical studies with fetal hemoglobin-enhancing agents in sickle cell disease.
- Approaches to the reactivation of hemoglobin F as a treatment for sickle cell disease.
- The evolving role of DNA demethylating agents in the treatment of sickle cell disease and thalassemia.
- Standard clinical practice underestimates the role and significance of erythropoietin deficiency in sickle cell disease.
- DNA hypo-methylating agents and sickle cell disease.
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Thomas Jefferson University -
Drexel University College of Medicine
Hospital
-
Thomas Jefferson University Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Paul C. McGovern, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gregory P. Bisson, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Prakash Bhuyan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amy Y. Vittor, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Olukemi A. Osinusi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ji Hoon Baang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carol T. Hu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ramin S. Herati, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen J. Gluckman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sarah R. Perloff, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Allison J. Sigler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David A. Pegues, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|